[5-[6-(3,4-dimethylanilino)imidazo[1,2-b]pyridazin-3-yl]thiophen-2-yl]methanol;4-[[3-(1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;methane;4-[[3-(5-methyl-1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;4-[[3-(6-methyl-1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;4-[[3-(7-methyl-1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;3-[(3-naphthalen-1-ylimidazo[1,2-b]pyridazin-6-yl)amino]propan-1-ol
C125H142N28O6S — CID 158095126
Data last refreshed: (MolForge compound catalog, from PubChem)
About [5-[6-(3,4-dimethylanilino)imidazo[1,2-b]pyridazin-3-yl]thiophen-2-yl]methanol;4-[[3-(1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;methane;4-[[3-(5-methyl-1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;4-[[3-(6-methyl-1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;4-[[3-(7-methyl-1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;3-[(3-naphthalen-1-ylimidazo[1,2-b]pyridazin-6-yl)amino]propan-1-ol
[5-[6-(3,4-dimethylanilino)imidazo[1,2-b]pyridazin-3-yl]thiophen-2-yl]methanol;4-[[3-(1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;methane;4-[[3-(5-methyl-1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;4-[[3-(6-methyl-1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;4-[[3-(7-methyl-1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;3-[(3-naphthalen-1-ylimidazo[1,2-b]pyridazin-6-yl)amino]propan-1-ol (PubChem CID 158095126) has the molecular formula C125H142N28O6S and a molecular weight of 2164.77 g/mol. Its IUPAC name is [5-[6-(3,4-dimethylanilino)imidazo[1,2-b]pyridazin-3-yl]thiophen-2-yl]methanol;4-[[3-(1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;methane;4-[[3-(5-methyl-1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;4-[[3-(6-methyl-1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;4-[[3-(7-methyl-1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;3-[(3-naphthalen-1-ylimidazo[1,2-b]pyridazin-6-yl)amino]propan-1-ol.
Molecular Properties
| Compound Name | [5-[6-(3,4-dimethylanilino)imidazo[1,2-b]pyridazin-3-yl]thiophen-2-yl]methanol;4-[[3-(1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;methane;4-[[3-(5-methyl-1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;4-[[3-(6-methyl-1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;4-[[3-(7-methyl-1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;3-[(3-naphthalen-1-ylimidazo[1,2-b]pyridazin-6-yl)amino]propan-1-ol |
|---|---|
| PubChem CID | 158095126 |
| Molecular Formula | C125H142N28O6S |
| Molecular Weight | 2164.77 g/mol |
| Exact Mass | 2163.14 |
| IUPAC Name | [5-[6-(3,4-dimethylanilino)imidazo[1,2-b]pyridazin-3-yl]thiophen-2-yl]methanol;4-[[3-(1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;methane;4-[[3-(5-methyl-1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;4-[[3-(6-methyl-1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;4-[[3-(7-methyl-1H-indol-2-yl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexan-1-ol;3-[(3-naphthalen-1-ylimidazo[1,2-b]pyridazin-6-yl)amino]propan-1-ol |
| SMILES | C.C.C.C.Cc1ccc(Nc2ccc3ncc(-c4ccc(CO)s4)n3n2)cc1C.Cc1ccc2[nH]c(-c3cnc4ccc(NC5CCC(O)CC5)nn34)cc2c1.Cc1ccc2cc(-c3cnc4ccc(NC5CCC(O)CC5)nn34)[nH]c2c1.Cc1cccc2cc(-c3cnc4ccc(NC5CCC(O)CC5)nn34)[nH]c12.OC1CCC(Nc2ccc3ncc(-c4cc5ccccc5[nH]4)n3n2)CC1.OCCCNc1ccc2ncc(-c3cccc4ccccc34)n2n1 |
| InChI | InChI=1S/3C21H23N5O.C20H21N5O.C19H18N4OS.C19H18N4O.4CH4/c1-13-2-7-17-14(10-13)11-18(24-17)19-12-22-21-9-8-20(25-26(19)21)23-15-3-5-16(27)6-4-15;1-13-2-3-14-11-18(24-17(14)10-13)19-12-22-21-9-8-20(25-26(19)21)23-15-4-6-16(27)7-5-15;1-13-3-2-4-14-11-17(24-21(13)14)18-12-22-20-10-9-19(25-26(18)20)23-15-5-7-16(27)8-6-15;26-15-7-5-14(6-8-15)22-19-9-10-20-21-12-18(25(20)24-19)17-11-13-3-1-2-4-16(13)23-17;1-12-3-4-14(9-13(12)2)21-18-7-8-19-20-10-16(23(19)22-18)17-6-5-15(11-24)25-17;24-12-4-11-20-18-9-10-19-21-13-17(23(19)22-18)16-8-3-6-14-5-1-2-7-15(14)16;;;;/h2,7-12,15-16,24,27H,3-6H2,1H3,(H,23,25);2-3,8-12,15-16,24,27H,4-7H2,1H3,(H,23,25);2-4,9-12,15-16,24,27H,5-8H2,1H3,(H,23,25);1-4,9-12,14-15,23,26H,5-8H2,(H,22,24);3-10,24H,11H2,1-2H3,(H,21,22);1-3,5-10,13,24H,4,11-12H2,(H,20,22);4*1H4 |
| InChIKey | FOONTRWCLQMSSK-UHFFFAOYSA-N |
| XLogP | 25.50 |
| TPSA | 437.86 Ų |
| H-Bond Donors | 16 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 160 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2164.77 |
| LogP ≤ 5 | 25.50 |
| H-Bond Donors ≤ 5 | 16 |
| H-Bond Acceptors ≤ 10 | 31 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158095126 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.